MAS1 and uveitis: Nevertheless, in most cases, since it takes a few weeks for the transferred gene to be functional and since it is impossible to treat the patients preventively, we can’t modify the ACE2/Ang-(1–7)/Mas axis for the initial uveitis patients by gene therapy in a timely manner.